-The Economic Times Anshu Prakash is worried about what he calls "mischievous propaganda" by "some people" who he thinks are misleading reporters. The joint secretary at the ministry of health and family welfare starts off by flatly denying that the joint monitoring mission (JMM) set up by the World Health Organization (WHO) and the government of India (GoI) discussed the impending danger of a TB drugs stock-out in August 2012. "There was...
More »SEARCH RESULT
Total Matching Records found : 8801
Refund order to Alchemist Infra
-The Telegraph Kolkata: Sebi has barred Alchemist Infra Realty Ltd from continuing its collective investment scheme and ordered that investors, several of whom are said to be in Bengal, be refunded within three months. The capital market watchdog's order said the company had denied it had anything to do with Alchemist Group, which is run by the family of K.D. Singh, a Rajya Sabha member from the Trinamul Congress. Some party leaders...
More »UN warns India against disaster risks in major PPP projects -Pradeep Thakur
-The Times of India NEW DELHI: A United Nations (UN) report has warned India that it is at greater risk by opting for public private partnership (PPP) mode of investment for raising its public infrastructure where the government has less control over its executing private partners and the latter has little interest in long term safety of the projects. A UN study, the Global Assessment Report (GAR) on disaster risk reduction, released...
More »Recipe for disaster in Uttarakhand: 1 crore population, 2.5 crore tourists -Subodh Varma
-The Times of India NEW DELHI: Are you surprised by the staggering number of people, many from across India, who are stranded in calamity-stricken Uttarakhand? The reason is quite simple: in a state with a total population of just over 1 crore, the number of tourists visiting it is 2.5 crore, both figures being for 2011. And most of these tourists visit the mountain state in summer. Put this together with the...
More »Indian drug makers face heat of US regulator's crackdown-Sushmi Dey
-The Business Standard Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...
More »
